Oops! Something went wrong, please try again later.
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
What data were you most excited to see presented at ASCO in RCC?
A:
A couple of biomarker studies were presented—abstracts, 4504, 4505, and 4506—from prospective, large phase 3 studies. We have a number of combinations that we...